Merck KGaA to receive up to €40 million in US tariff refunds for life science business through 2026
read at Endpoints ↗RegulatoryPositive
Merck KGaA announced that it expects to receive tariff refunds for its life‑science division after a US Supreme Court ruling.
The company estimates the refunds will total roughly €40 million and will be paid out through the end of 2026.
The refunds arise because the Court blocked several tariffs that had been imposed under the previous administration.
Merck says the reimbursement will help offset costs for its life‑science customers and improve its financial position.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Merck KGaA readies tariff refunds worth €40M for life science customers”
read at Endpoints ↗82 words · retrieved Aug 6
comments(0)
5-min edit window · permanent after that